These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28717899)
21. The impact of disclosing financial ties in research and clinical care: a systematic review. Licurse A; Barber E; Joffe S; Gross C Arch Intern Med; 2010 Apr; 170(8):675-82. PubMed ID: 20421551 [TBL] [Abstract][Full Text] [Related]
22. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data. Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611 [TBL] [Abstract][Full Text] [Related]
23. The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' Payments. Winn AN; Mitchell AP; Fergestrom N; Neuner JM; Trogdon JG J Gen Intern Med; 2021 Jul; 36(7):1858-1866. PubMed ID: 33904046 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines. Horn J; Checketts JX; Jawhar O; Vassar M JAMA Otolaryngol Head Neck Surg; 2018 Mar; 144(3):194-201. PubMed ID: 29270633 [TBL] [Abstract][Full Text] [Related]
25. Association of Compensation From the Surgical and Medical Device Industry to Physicians and Self-declared Conflict of Interest. Ziai K; Pigazzi A; Smith BR; Nouri-Nikbakht R; Nepomuceno H; Carmichael JC; Mills S; Stamos MJ; Jafari MD JAMA Surg; 2018 Nov; 153(11):997-1002. PubMed ID: 30140910 [TBL] [Abstract][Full Text] [Related]
26. Industry compensation and self-reported financial conflicts of interest among authors of highly cited peripheral artery disease studies. Bellomo TR; Hwang C; Spector-Bagdady K; Stanley JC; Corriere MA J Vasc Surg; 2020 Aug; 72(2):673-684. PubMed ID: 31980241 [TBL] [Abstract][Full Text] [Related]
27. Accuracy Between AJSM Author-Reported Disclosures and the Centers for Medicare and Medicaid Services Open Payments Database. Boddapati V; Fu MC; Nwachukwu BU; Ranawat AS; Zhen WY; Dines JS Am J Sports Med; 2018 Mar; 46(4):969-976. PubMed ID: 29382212 [TBL] [Abstract][Full Text] [Related]
28. Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust. Klein E; Solomon AJ; Corboy J; Bernat J Mult Scler Relat Disord; 2016 Jul; 8():4-8. PubMed ID: 27456867 [TBL] [Abstract][Full Text] [Related]
29. Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study. Raftery J; Bryant J; Powell J; Kerr C; Hawker S Health Technol Assess; 2008 Apr; 12(10):1-128, iii. PubMed ID: 18405468 [TBL] [Abstract][Full Text] [Related]
30. Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016. Stoll M; Hubenschmid L; Koch C; Lieb K BMJ Open; 2020 Sep; 10(9):e037395. PubMed ID: 32948560 [TBL] [Abstract][Full Text] [Related]
31. Association Between Public Trust and Provider Specialty Among Physicians With Financial Conflicts of Interest. Niforatos JD; Chaitoff A; Mercer MB; Yu PC; Rose SL Mayo Clin Proc; 2019 Dec; 94(12):2467-2475. PubMed ID: 31806100 [TBL] [Abstract][Full Text] [Related]
32. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures. Pokorny AMJ; Bero LA; Moynihan R; Mintzes BJ Intern Med J; 2021 Nov; 51(11):1816-1824. PubMed ID: 32744396 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of Financial Conflicts of Interest Among Physician-Authors of American College of Rheumatology Clinical Practice Guidelines. Wayant C; Walters C; Zaaza Z; Gilstrap C; Combs T; Crow H; Vassar M Arthritis Rheumatol; 2020 Sep; 72(9):1427-1434. PubMed ID: 32039569 [TBL] [Abstract][Full Text] [Related]
35. [Psychiatrists and the pharmaceutical industry]. Helmchen H Nervenarzt; 2003 Nov; 74(11):955-64. PubMed ID: 14694885 [TBL] [Abstract][Full Text] [Related]
36. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide. Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536 [TBL] [Abstract][Full Text] [Related]
37. Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. Ross JS; Lackner JE; Lurie P; Gross CP; Wolfe S; Krumholz HM JAMA; 2007 Mar; 297(11):1216-23. PubMed ID: 17374816 [TBL] [Abstract][Full Text] [Related]
38. Conflict of interest in clinical practice. Tonelli MR Chest; 2007 Aug; 132(2):664-70. PubMed ID: 17699138 [TBL] [Abstract][Full Text] [Related]
39. A systematic review of state and manufacturer physician payment disclosure websites: implications for implementation of the Sunshine Act. Hwong AR; Qaragholi N; Carpenter D; Joffe S; Campbell EG; Soleymani Lehmann L J Law Med Ethics; 2014; 42(2):208-19. PubMed ID: 25040384 [TBL] [Abstract][Full Text] [Related]
40. Types and Distribution of Payments From Industry to Physicians in 2015. Tringale KR; Marshall D; Mackey TK; Connor M; Murphy JD; Hattangadi-Gluth JA JAMA; 2017 May; 317(17):1774-1784. PubMed ID: 28464140 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]